BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27498810)

  • 1. [Medullary thyroid carcinoma in a 10-month-old child with multiple endocrine neoplasia 2B].
    Mathiesen JS; Døssing H; Bender L; Godballe C
    Ugeskr Laeger; 2014 Jan; 176(5A):. PubMed ID: 27498810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnosis of multiple endocrine neoplasia type 2B: a challenge for physicians.
    Camacho CP; Hoff AO; Lindsey SC; Signorini PS; Valente FO; Oliveira MN; Kunii IS; Biscolla RP; Cerutti JM; Maciel RM
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1393-8. PubMed ID: 19169500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive medullary thyroid carcinoma in a ten-year-old patient with multiple endocrine neoplasia 2B due to the A883F mutation.
    Mathiesen JS; Stochholm K; Poulsen PL; Vestergaard EM; Christiansen P; Vestergaard P
    Thyroid; 2015 Jan; 25(1):139-40. PubMed ID: 25244518
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple endocrine neoplasia type 2B.
    Nakata S; Okugi H; Saitoh Y; Takahashi H; Shimizu K
    Int J Urol; 2001 Jul; 8(7):398-400. PubMed ID: 11442663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.
    Qi XP; Lin GB; Chen B; Li F; Cao ZL; Zheng WH; Zhao JQ
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):554-560. PubMed ID: 32660411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel tandem germline RET proto-oncogene mutations in a patient with multiple endocrine neoplasia type 2B: report of a case and a literature review of tandem RET mutations with in silico analysis.
    Nakao KT; Usui T; Ikeda M; Mori Y; Yamamoto T; Kawashima ST; Nanba K; Yuno A; Tamanaha T; Tagami T; Naruse M; Asato R; Shimatsu A
    Head Neck; 2013 Dec; 35(12):E363-8. PubMed ID: 23468374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K; Raue F
    Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
    Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
    J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid carcinoma in a 2-month-old male with multiple endocrine neoplasia 2B and symptoms of pseudo-Hirschsprung disease: a case report.
    Unruh A; Fitze G; Jänig U; Bielack S; Lochbühler H; Coerdt W
    J Pediatr Surg; 2007 Sep; 42(9):1623-6. PubMed ID: 17848262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary thyroid carcinoma in children.
    Viola D; Romei C; Elisei R
    Endocr Dev; 2014; 26():202-13. PubMed ID: 25231454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the RET proto-oncogene in medullary thyroid carcinoma.
    Höppner W
    Clin Lab; 2007; 53(5-6):283-4. PubMed ID: 17605402
    [No Abstract]   [Full Text] [Related]  

  • 12. The Reality of Multiple Endocrine Neoplasia Type 2B Diagnosis: Awareness of Unique Physical Appearance Is Important.
    Nagaoka R; Sugitani I; Sanada M; Jikuzono T; Okamura R; Igarashi T; Akasu H; Shimizu K
    J Nippon Med Sch; 2018; 85(3):178-182. PubMed ID: 30135345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
    Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L
    Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to recognize multiple endocrine neoplasia 2B: more common than we think?
    Wray CJ; Rich TA; Waguespack SG; Lee JE; Perrier ND; Evans DB
    Ann Surg Oncol; 2008 Jan; 15(1):293-301. PubMed ID: 17963006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan.
    Kameyama K; Okinaga H; Takami H
    Biomed Pharmacother; 2004; 58(6-7):345-7. PubMed ID: 15271413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric medullary carcinoma of the thyroid with point mutation of RET proto-oncogene associated with multiple endocrine neoplasia and initially diagnosed by fine-needle aspiration biopsy.
    Chai C; Lemos LB; Kaelbling M; Baliga M
    South Med J; 2003 Mar; 96(3):287-90. PubMed ID: 12659362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW; Appfelstaedt J; Zaahl MG
    J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathology of preclinical medullary thyroid carcinoma.
    Ashworth M
    Endocr Pathol; 2004; 15(3):227-31. PubMed ID: 15640548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New Millennium.
    Raue F; Dralle H; Machens A; Bruckner T; Frank-Raue K
    J Clin Endocrinol Metab; 2018 Jan; 103(1):235-243. PubMed ID: 29077903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current approaches to medullary thyroid carcinoma, sporadic and familial.
    Fialkowski EA; Moley JF
    J Surg Oncol; 2006 Dec; 94(8):737-47. PubMed ID: 17131404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.